Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

NCT00478660 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00478660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00478660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
Not reported
Enrollment
1,250 (actual)
Sites
205

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis